Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Connect Biopharma Holdings (CNTB) EBIT Margin (2024 - 2025)

Historic EBIT Margin for Connect Biopharma Holdings (CNTB) over the last 2 years, with Q3 2025 value amounting to 110481.25%.

  • Connect Biopharma Holdings' EBIT Margin fell 1093454000.0% to 110481.25% in Q3 2025 from the same period last year, while for Sep 2025 it was 6846.06%, marking a year-over-year change of. This contributed to the annual value of 86.24% for FY2024, which is N/A changed from last year.
  • Latest data reveals that Connect Biopharma Holdings reported EBIT Margin of 110481.25% as of Q3 2025, which was down 1093454000.0% from 27966.67% recorded in Q2 2025.
  • Connect Biopharma Holdings' EBIT Margin's 5-year high stood at 1135.85% during Q3 2024, with a 5-year trough of 110481.25% in Q3 2025.